Circulating MicroRNA-122-5p Is Associated With a Lack of Improvement in Left Ventricular Function After Transcatheter Aortic Valve Replacement and Regulates Viability of Cardiomyocytes Through Extracellular Vesicles
- PMID: 35862223
- DOI: 10.1161/CIRCULATIONAHA.122.060258
Circulating MicroRNA-122-5p Is Associated With a Lack of Improvement in Left Ventricular Function After Transcatheter Aortic Valve Replacement and Regulates Viability of Cardiomyocytes Through Extracellular Vesicles
Abstract
Background: Transcatheter aortic valve replacement (TAVR) is a well-established treatment option for high- and intermediate-risk patients with severe symptomatic aortic valve stenosis. A majority of patients exhibit improvements in left ventricular ejection fraction (LVEF) after TAVR in response to TAVR-associated afterload reduction. However, a specific role for circulating microRNAs (miRNAs) in the improvement of cardiac function for patients after TAVR has not yet been investigated. Here, we profiled the differential expression of miRNAs in circulating extracellular vesicles (EVs) in patients after TAVR and, in particular, the novel role of circulating miR-122-5p in cardiomyocytes.
Methods: Circulating EV-associated miRNAs were investigated by use of an unbiased Taqman-based human miRNA array. Several EV miRNAs (miR-122-5p, miR-26a, miR-192, miR-483-5p, miR-720, miR-885-5p, and miR-1274) were significantly deregulated in patients with aortic valve stenosis at day 7 after TAVR compared with the preprocedural levels in patients without LVEF improvement. The higher levels of miR-122-5p were negatively correlated with LVEF improvement at both day 7 (r=-0.264 and P=0.015) and 6 months (r=-0.328 and P=0.0018) after TAVR.
Results: Using of patient-derived samples and a murine aortic valve stenosis model, we observed that the expression of miR-122-5p correlates negatively with cardiac function, which is associated with LVEF. Mice with graded wire injury-induced aortic valve stenosis demonstrated a higher level of miR-122-5p, which was related to cardiomyocyte dysfunction. Murine ex vivo experiments revealed that miR-122-5p is highly enriched in endothelial cells compared with cardiomyocytes. Coculture experiments, copy-number analysis, and fluorescence microscopy with Cy3-labeled miR-122-5p demonstrated that miR-122-5p can be shuttled through large EVs from endothelial cells into cardiomyocytes. Gain- and loss-of-function experiments suggested that EV-mediated shuttling of miR-122-5p increases the level of miR-122-5p in recipient cardiomyocytes. Mechanistically, mass spectrometry, miRNA pulldown, electrophoretic mobility shift assay, and RNA immunoprecipitation experiments confirmed that miR-122-5p interacts with the RNA-binding protein hnRNPU (heterogeneous nuclear ribonucleoprotein U) in a sequence-specific manner to encapsulate miR-122-5p into large EVs. On shuttling, miR-122-5p reduces the expression of the antiapoptotic gene BCL2 by binding to its 3' untranslated region to inhibit its translation, thereby decreasing the viability of target cardiomyocytes.
Conclusions: Increased levels of circulating proapoptotic EV-incorporated miR-122-5p are associated with reduced LVEF after TAVR. EV shuttling of miR-122-5p regulates the viability and apoptosis of cardiomyocytes in a BCL2-dependent manner.
Keywords: cardiovascular diseases; endothelial cells; extracellular vesicles; microRNAs; myocytes, cardiac; transcatheter aortic valve replacement.
Comment in
-
Letter by Li et al Regarding Article, "Circulating MicroRNA-122-5p Is Associated With a Lack of Improvement in Left Ventricular Function After Transcatheter Aortic Valve Replacement and Regulates Viability of Cardiomyocytes Through Extracellular Vesicles".Circulation. 2023 Jan 24;147(4):e66-e67. doi: 10.1161/CIRCULATIONAHA.122.062221. Epub 2023 Jan 23. Circulation. 2023. PMID: 36689570 No abstract available.
-
Letter by Gutmann et al Regarding Article, "Circulating MicroRNA-122-5p Is Associated With a Lack of Improvement in Left Ventricular Function After Transcatheter Aortic Valve Replacement and Regulates Viability of Cardiomyocytes Through Extracellular Vesicles".Circulation. 2023 Jan 24;147(4):e68-e69. doi: 10.1161/CIRCULATIONAHA.122.062334. Epub 2023 Jan 23. Circulation. 2023. PMID: 36689571 No abstract available.
-
Letter by Halushka and Witwer Regarding Article, "Circulating MicroRNA-122-5p Is Associated With a Lack of Improvement in Left Ventricular Function After Transcatheter Aortic Valve Replacement and Regulates Viability of Cardiomyocytes Through Extracellular Vesicles".Circulation. 2023 Jan 24;147(4):e64-e65. doi: 10.1161/CIRCULATIONAHA.122.061834. Epub 2023 Jan 23. Circulation. 2023. PMID: 36689572 Free PMC article. No abstract available.
Similar articles
-
Letter by Halushka and Witwer Regarding Article, "Circulating MicroRNA-122-5p Is Associated With a Lack of Improvement in Left Ventricular Function After Transcatheter Aortic Valve Replacement and Regulates Viability of Cardiomyocytes Through Extracellular Vesicles".Circulation. 2023 Jan 24;147(4):e64-e65. doi: 10.1161/CIRCULATIONAHA.122.061834. Epub 2023 Jan 23. Circulation. 2023. PMID: 36689572 Free PMC article. No abstract available.
-
Letter by Li et al Regarding Article, "Circulating MicroRNA-122-5p Is Associated With a Lack of Improvement in Left Ventricular Function After Transcatheter Aortic Valve Replacement and Regulates Viability of Cardiomyocytes Through Extracellular Vesicles".Circulation. 2023 Jan 24;147(4):e66-e67. doi: 10.1161/CIRCULATIONAHA.122.062221. Epub 2023 Jan 23. Circulation. 2023. PMID: 36689570 No abstract available.
-
Letter by Gutmann et al Regarding Article, "Circulating MicroRNA-122-5p Is Associated With a Lack of Improvement in Left Ventricular Function After Transcatheter Aortic Valve Replacement and Regulates Viability of Cardiomyocytes Through Extracellular Vesicles".Circulation. 2023 Jan 24;147(4):e68-e69. doi: 10.1161/CIRCULATIONAHA.122.062334. Epub 2023 Jan 23. Circulation. 2023. PMID: 36689571 No abstract available.
-
Cardiac structural changes after transcatheter aortic valve replacement: systematic review and meta-analysis of cardiovascular magnetic resonance studies.J Cardiovasc Magn Reson. 2020 Jun 1;22(1):41. doi: 10.1186/s12968-020-00629-9. J Cardiovasc Magn Reson. 2020. PMID: 32475350 Free PMC article.
-
Prognostic Value of Preprocedural LV Global Longitudinal Strain for Post-TAVR-Related Morbidity and Mortality: A Meta-Analysis.JACC Cardiovasc Imaging. 2023 Mar;16(3):332-341. doi: 10.1016/j.jcmg.2023.01.005. JACC Cardiovasc Imaging. 2023. PMID: 36889849
Cited by
-
Regression of cardiac hypertrophy in health and disease: mechanisms and therapeutic potential.Nat Rev Cardiol. 2023 May;20(5):347-363. doi: 10.1038/s41569-022-00806-6. Epub 2023 Jan 4. Nat Rev Cardiol. 2023. PMID: 36596855 Free PMC article. Review.
-
Decreased in n-3 DHA enriched triacylglycerol in small extracellular vesicles of diabetic patients with cardiac dysfunction.J Diabetes. 2023 Dec;15(12):1070-1080. doi: 10.1111/1753-0407.13457. Epub 2023 Aug 18. J Diabetes. 2023. PMID: 37593852 Free PMC article.
-
Exploring the role of epicardial adipose-tissue-derived extracellular vesicles in cardiovascular diseases.iScience. 2024 Feb 29;27(4):109359. doi: 10.1016/j.isci.2024.109359. eCollection 2024 Apr 19. iScience. 2024. PMID: 38510143 Free PMC article. Review.
-
Endothelial derived, secreted long non-coding RNAs Gadlor1 and Gadlor2 aggravate cardiac remodeling.Mol Ther Nucleic Acids. 2024 Aug 15;35(3):102306. doi: 10.1016/j.omtn.2024.102306. eCollection 2024 Sep 10. Mol Ther Nucleic Acids. 2024. PMID: 39281699 Free PMC article.
-
Human and porcine aortic valve endothelial and interstitial cell isolation and characterization.Front Cardiovasc Med. 2023 Jun 20;10:1151028. doi: 10.3389/fcvm.2023.1151028. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37408661 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources